Clinical Trial Update: The Use of Finasteride to Reduce Hematuria and Hematospermia Following TRUS Prostate Biopsy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating finasteride to reduce hematuria and hematospermia after transrectal ultrasound-guided prostate biopsy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematospermia
• Hematuria

Drugs mentioned

• FINASTERIDE (FINASTERIDE)

Snippet

Sponsor: University of British Columbia | Conditions: Hematuria, Hematospermia | Phase 2 | Status: TERMINATED